Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab - Université de Bourgogne Accéder directement au contenu
Poster De Conférence Année : 2017
Fichier non déposé

Dates et versions

hal-01685193 , version 1 (16-01-2018)

Identifiants

  • HAL Id : hal-01685193 , version 1

Citer

A. Fromont, R.O. Casasnovas, C. Billy, L. Martin, Thibault Moreau. Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Oct 2017, Paris, France. , Multiple Sclerosis Journal, 23 (Supplement 3), pp.927 (EP1760), 2017. ⟨hal-01685193⟩
19 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More